Results 71 to 80 of about 113,181 (243)

Nanoparticles in microdroplets: Recent advances in microfluidic generators for producing functional microbeads

Droplet, EarlyView.
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
  Bayinqiaoge, Chengchen Zhang, Shi‐Yang Tang   +2 more
wiley   +1 more source

Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2021
Abdullah Ely, Kristie Bloom, Mohube Betty Maepa, Patrick Arbuthnot Wits/SAMRC Antiviral Gene Therapy Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCorrespondence: Patrick ...
Ely A, Bloom K, Maepa MB, Arbuthnot P
doaj  

Microengineering the Liver: Strategies for Constructing Functional Liver‐on‐a‐Chip Devices

Exploration, EarlyView.
This review summarizes recent advances in liver‐on‐a‐chip (LOC) technologies, including fabrication strategies and functional integration approaches, and discusses their promising applications in drug screening and related biomedical fields. ABSTRACT Reliable in vitro liver models are indispensable for researching liver diseases and developing ...
Jie Wang, Ziwei Liang, Jiapu Wang, Zongyi Li, Shaojie Wang, Yan Wei, Xin Xie, Di Huang   +7 more
wiley   +1 more source

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance

Human Vaccines & Immunotherapeutics, 2020
An effective prophylactic hepatitis B virus (HBV) vaccine has long been available but is ineffective for chronic infection. The primary cause of chronic hepatitis B (CHB) and greatest impediment for a therapeutic vaccine is the direct and indirect ...
DC Whitacre, CJ Peters, C Sureau, K Nio, F Li, L Su, JE Jones, M Isogawa, M Sallberg, L Frelin, DL Peterson, DR Milich   +11 more
doaj   +1 more source

Strategies for hepatitis B booster vaccination among children: an 8-year prospective cohort study

Human Vaccines & Immunotherapeutics, 2020
Debate continues regarding the need for a booster vaccination in children who received a universal infant hepatitis B virus (HBV) vaccination. The aim was to explore the need and the strategies for the booster HBV vaccination.
Yan Qiu, Jing-Jing Ren, Zi-Kang Wu, Ling-Zhi Shen, Huan Shan, Xue-Wei Dai, Jing Li, Ying Liu, Wen Ren, Jun Yao, Lan-Juan Li   +10 more
doaj   +1 more source

Prevalence of HIV and Its Co-Infection with Hepatitis B/C Virus Among Chronic Liver Disease Patients in Ethiopia

Hepatic Medicine: Evidence and Research, 2022
Yayehyirad Tassachew,1– 3 Tamrat Abebe,1 Yeshambel Belyhun,4 Tezazu Teffera,5 Abate Bane Shewaye,6,7 Hailemichael Desalegn,8 Henok Andualem,9 Abiy Kinfu,10 Andargachew Mulu,2 Adane Mihret,1,2 Rawleigh Howe,2 Abraham Aseffa2 1Department of Microbiology ...
Tassachew Y, Abebe T, Belyhun Y, Teffera T, Shewaye AB, Desalegn H, Andualem H, Kinfu A, Mulu A, Mihret A, Howe R, Aseffa A   +11 more
doaj  

Endringer i høyere utdanning – og endringer for UNIPED [PDF]

Uniped, 2014
Line Wittek
doaj   +1 more source

Late Onset Telomere Biology Disorder Presenting With Pancytopenia, Immune Dysregulation, Interstitial Lung Disease and Alopecia

American Journal of Hematology, EarlyView.
Bo A. Wan, Hamish Nicolson, Heather A. Leitch, Ryan J. Stubbins, Luke Y. C. Chen, Timothy Murray, Amy Trottier, Anthony Gador   +7 more
wiley   +1 more source

Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells

Journal of Hepatocellular Carcinoma, 2022
Cuifang Zhang,1,2 Ying Xie,3 Ruixue Lai,1 Jianhua Wu,4 Zhanjun Guo1 1Department of Rheumatology and Immunology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of Oncology, The Pingshan County People’
Zhang C, Xie Y, Lai R, Wu J, Guo Z
doaj  

Comparative Efficacy of Etiotropic Therapy of Patients with HBeAg-Positive Chronic Hepatitis B (by the Data of the International Comparative Placebo-Controlled Study)

Антибиотики и Химиотерапия, 2020
Comparative placebo-controlled study entrolled 647 patients with verified diagnosis of chronic virus hepatitis B (HBeAg+), not previously subjected to antiviral therapy (with nucleotide analogues or interferons).
V. V. Stelmakh, M. G. Romantsov, T. V. Sologub, A. A. Shuldyakov, V. K. Kozlov, N. Kh. Tuan, M. .. Ovungerel, V. M. Frolov   +7 more
doaj